Guiding
Principles on Restraint and Seclusion
for Behavioral Health Services
February
25, 1999
Preventing injury and
death related to the use of restraint and seclusion
is paramount.
The following
guidelines are based on the policies already in place
in our member institutions. By publicly issuing these
guidelines, the American Hospital Association (AHA)
and the National Association of Psychiatric Health
Systems (NAPHS) hope to heighten public awareness
about the appropriate use of restraint and seclusion.
We are asking our members to use these guidelines to
review their current policies and to make sure they
are implemented appropriately.
Restraint and
seclusion, when used properly, can be life-saving and
injury-sparing interventions.
- A patient's
overall treatment is based on a
comprehensive, individualized treatment plan
that includes appropriate patient and family
involvement.
- Hospitals and
other treatment settings serve individuals
with severe mental illnesses and substance
abuse problems who are, at times, dangerous
to themselves or others.
- Restraint and
seclusion should be used as infrequently as
possible, and only when less restrictive
methods are considered and are not feasible.
- Restraint and
seclusion are emergency interventions that
aim to protect patients in danger of harming
themselves or others and to enable patients
to continue treatment successfully and
effectively.
Prevention of
injury and death is essential.
- Hospitals and
other treatment settings must ensure that
staff are well-trained and continuously
educated regarding the proper use of
restraint and seclusion. Detailed policies,
procedures, and systems must be developed
with input from physicians and other mental
health professionals, and they must be
understood and followed by all staff. Areas
include:
| ~ |
assessment and crisis
prevention techniques |
| ~ |
use of least restrictive
methods |
| ~ |
how to employ restraint
and seclusion safely (including
understanding the risks and benefits
of either intervening or not
intervening) |
| ~ |
a process for
continuously reevaluating the need
for restraint or seclusion |
| ~ |
a process for continuous
monitoring to ensure the patient's
safety and other needs are met |
- A physician (or
other licensed practitioner as permitted by
state law) should authorize use of restraint
or seclusion in a timely manner. This
licensed clinician must be involved in the
decision to continue the use of restraint or
seclusion.
- Policies and
procedures should be reviewed and updated
continuously based on clinical outcomes.
- Because these
techniques have a potential for causing
injury or death, restraint and seclusion
policies must be a system-wide resource
priority. Adequate allocation of resources
and appropriate decision-making guidelines
within the institution must be in place.
- Consideration
should be given to the safe and appropriate
use of medication as an alternative to
restraint and seclusion and in reducing the
length of any episode.
Appropriate
oversight of restraint and seclusion is important.
- Federal
protections are in place through
accreditation and regulatory bodies such as
the Joint Commission on Accreditation of
Healthcare Organizations (JCAHO) and the
Health Care Financing Administration and
should be supported.
- State laws,
rules, and regulations enforced through
departments of public and mental health and
state licensure agencies also protect
patients' rights and should be used to assure
appropriate use of restraint and seclusion.
- Overregulation
based on narrowly defined problems could
divert limited resources to bureaucratic
activities. Patients are best served when
maximum dollars are devoted to appropriate
clinical care.
We are committed to
preventing injury and death.
- The NAPHS and AHA
are committed to working with consumers,
families, regulatory and accrediting
agencies, Congress, and others to ensure that
the systems designed to protect patients are
working, and that clear and appropriate
guidelines and standards are in place to
protect patients and maintain their dignity.
- Together with our
members, we must share guidelines and
information on appropriate and inappropriate
restraint and seclusion techniques issued by
clinical and regulatory bodies (such as the
American Psychiatric Association and JCAHO).
In addition, restraint and seclusion
procedures (or any other interventions) that
have been found to be best practices or,
conversely, have been found to be dangerous
should be widely and promptly communicated
within the field.
NAPHS
701 13th Street, NW, Suite 950
Washington, DC 20005-3903
Phone: 202/393-6700
Fax: 202/783-6041
E-mail: naphs@naphs.org
|